Moderna shares fall after judge sides with Arbutus in patent fight
(Reuters) -Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order that…
N2:VACCIN
Pfizer posts surprise 4th quarter profit, but key products miss on…
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit…
Pfizer looks beyond COVID after quarterly loss on Paxlovid charge
By Bhanvi Satija and Michael Erman (Reuters) - Pfizer on Tuesday urged investors to focus…
Scientists infect volunteers with Zika in hunt for vaccines,…
By Jennifer Rigby (Reuters) - Researchers in the United States have shown for the first…
New COVID shots still hard to find for some Americans
By Michael Erman and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) - Americans have…
About 4 million Americans got updated COVID vaccines in September
By Ahmed Aboulenein and Michael Erman (Reuters) -Around 4 million Americans received the…
US govt awards $1.4 billion for development of new COVID therapies,…
(Reuters) - The U.S. government said on Tuesday it had awarded $1.4 billion for the…
Moderna’s updated COVID vaccine effective against…
(Reuters) - Moderna said on Thursday an initial study data showed its updated COVID-19…
J&J upbeat on 2023 as devices rebound post-COVID, shares jump
By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday…